GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (TSXV:VPT) » Definitions » Revenue

VentriPoint Diagnostics (TSXV:VPT) Revenue : C$0.05 Mil (TTM As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is VentriPoint Diagnostics Revenue?

VentriPoint Diagnostics's revenue for the three months ended in Dec. 2023 was C$0.04 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.05 Mil. VentriPoint Diagnostics's Revenue per Share for the three months ended in Dec. 2023 was C$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, VentriPoint Diagnostics's highest 3-Year average Revenue per Share Growth Rate was 17.00% per year. The lowest was -59.50% per year. And the median was -36.10% per year.


VentriPoint Diagnostics Revenue Historical Data

The historical data trend for VentriPoint Diagnostics's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics Revenue Chart

VentriPoint Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.04 - 0.07 0.05

VentriPoint Diagnostics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 - - - 0.04

Competitive Comparison of VentriPoint Diagnostics's Revenue

For the Medical Devices subindustry, VentriPoint Diagnostics's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VentriPoint Diagnostics's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Revenue distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's Revenue falls into.



VentriPoint Diagnostics Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VentriPoint Diagnostics  (TSXV:VPT) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


VentriPoint Diagnostics Revenue Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


VentriPoint Diagnostics (TSXV:VPT) Business Description

Traded in Other Exchanges
Address
18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.
Executives
Robert Hodgkinson Director

VentriPoint Diagnostics (TSXV:VPT) Headlines

No Headlines